Literature DB >> 17301837

Colchicine promotes antigen cross-presentation by murine dendritic cells.

Norikatsu Mizumoto, Hiroaki Tanaka, Hironori Matsushima, Mridula Vishwanath, Akira Takashima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17301837     DOI： 10.1038/sj.jid.5700699

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  8 in total

1.  Classification of chemotherapeutic agents based on their differential in vitro effects on dendritic cells.

Authors:  Hiroaki Tanaka; Hironori Matsushima; Norikatsu Mizumoto; Akira Takashima
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

Review 2.  Colchicine--Update on mechanisms of action and therapeutic uses.

Authors:  Ying Ying Leung; Laura Li Yao Hui; Virginia B Kraus
Journal:  Semin Arthritis Rheum       Date:  2015-06-26       Impact factor: 5.532

3.  Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines.

Authors:  Chih-Chun Wen; Hui-Ming Chen; Swey-Shen Chen; Li-Ting Huang; Wei-Ting Chang; Wen-Chi Wei; Li-Chen Chou; Palanisamy Arulselvan; Jin-Bin Wu; Sheng-Chu Kuo; Ning-Sun Yang
Journal:  J Biomed Sci       Date:  2011-06-20       Impact factor: 8.410

Review 4.  Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs.

Authors:  Kea Martin; Jens Schreiner; Alfred Zippelius
Journal:  Front Immunol       Date:  2015-09-29       Impact factor: 7.561

5.  GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor Responses.

Authors:  Abhishek S Kashyap; Laura Fernandez-Rodriguez; Yun Zhao; Gianni Monaco; Marcel P Trefny; Naohiro Yoshida; Kea Martin; Ashwani Sharma; Natacha Olieric; Pankaj Shah; Michal Stanczak; Nicole Kirchhammer; Sung-Moo Park; Sebastien Wieckowski; Heinz Laubli; Rachid Zagani; Benjamin Kasenda; Michel O Steinmetz; Hans-Christian Reinecker; Alfred Zippelius
Journal:  Cell Rep       Date:  2019-09-24       Impact factor: 9.423

Review 6.  Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features.

Authors:  Foad Rommasi; Mohammad Javad Nasiri; Mehdi Mirsaeidi
Journal:  Mol Cell Biochem       Date:  2022-01-11       Impact factor: 3.842

7.  Immunomodulatory effects of preparations from Anthroposophical Medicine for parenteral use.

Authors:  Carsten Gründemann; Christoph Diegel; Barbara Sauer; Manuel Garcia-Käufer; Roman Huber
Journal:  BMC Complement Altern Med       Date:  2015-07-09       Impact factor: 3.659

Review 8.  The Potential of Combining Tubulin-Targeting Anticancer Therapeutics and Immune Therapy.

Authors:  Alexis Fong; Amanda Durkin; Hoyun Lee
Journal:  Int J Mol Sci       Date:  2019-01-30       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.